can glp-1 cause weight gain Glucagon-like peptide-1 receptor agonists and muscle mass effects GLP‑1 Drugs: Obesity & Diabetes

Data on whether tirzepatide lowers cardiovascular outcomes is not expected until 2025

Taking one of the new GLP-1s is not a short-term solution

10.2337/db23-0553 40 KahlesF.MeyerC.MollmannJ.DieboldS.FindeisenH

Kieffer et al

Patients should receive clear written and verbal information about: Expected side effects of each medication Warning signs requiring immediate medical attention (severe abdominal pain, persistent vomiting, signs of pancreatitis, mood changes, suicidal thoughts) The importance of adherence to prescribed doses Lifestyle modifications to support treatment goals Multidisciplinary coordination may be beneficial, particularly when care involves both smoking cessation services and weight management clinics